Search Results 191-200 of 16990 for Conduction

1. A Study to Compare Venetoclax with Fulvestrant vs. Fulvestrant Alone in Women with Locally Advanced or Metastatic HER2-negative Cancer who Have Progressed or Recurred on a CDK4/6 Inhibitor - Mayo Clinic

   Angina pectoris requiring anti-anginal medication, serious cardiac arrhythmia not controlled by adequate medication, severe conduction abnormality, or ...

2. A Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical Treatment - Mayo Clinic

   Clinically significant abnormalities detected on ECG of either rhythm or conduction, a QTcF > 450 ms, or a known long QT syndrome. Patients with implantable ...

3. Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients - Mayo Clinic

   Patients with permanent AF are excluded if they have intact AV node conduction (RV pacing < 95%). Already included in another clinical study that could ...

4. Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia - Mayo Clinic

   ... conduction system abnormalities are not eligible. Patients who have known gastrointestinal (GI) disease or GI procedures which could interfere with the oral ...

5. Spine Care - Doctors - Mayo Clinic

   ... conduction study, Neuromuscular ultrasound, Facet joint injection, Cyst aspiration, Sacroiliac joint injection, Neurophysiological assessment, Functional ...

6. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

   ... conduction abnormalities. Patients with history of cardiac disease, such as coronary disease, arrhythmia or congestive heart failure that are on appropriate ...

7. A Study to Evaluate the Effectiveness and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis - Mayo Clinic

   The subject has any clinically important abnormalities in rate, rhythm, conduction, or morphology of resting ECG. The subject has prolonged QTcF interval ...

8. Aortic Valve Disease Clinical Trials - Mayo Clinic Research

   Total Study Duration is ... Cara CDRM (Conduction Disturbance Risk Monitor) 2.0 Rochester, MN. The purpose of this study is to establish the safety of using ...

9. Spine Care - Doctors - Mayo Clinic

   ... conduction study, Neuromuscular ultrasound, Facet joint injection, Cyst aspiration, Sacroiliac joint injection, Neurophysiological assessment, Functional ...

10. Study of INCB053914 in Subjects With Advanced Malignancies - Mayo Clinic

    For subjects with an intraventricular conduction delay (QRS interval 120 msec), the JTc interval may be used in place of the QTc with sponsor approval.